What is Dental Carpule Market?
Dental carpule is a small, cylindrical glass tube often covered with a plastic coating that is used to maintain and deliver dental anesthetics used in various dental procedures. It is a single-use item that is designed to be used by one patient only and then it is disposed of. Increased prevalence of dental diseases and a rise in the number of dental procedures worldwide will drive the dental carpule market.
Highlights from Dental Carpule Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
Key Companies Profiled | GlaxoSmithKline plc (United Kingdom), AstraZeneca (United Kingdom), Gilead Sciences, Inc. (United States), Sanofi (France), Merck & Co., Inc. (United States), Roche Holding AG (Switzerland), Pfizer, Inc. (United States), Novartis (Switzerland), Kulzer GmbH (Germany) and 3M (United States) |
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Dental Carpule market throughout the forecasted period.
GlaxoSmithKline plc (United Kingdom), AstraZeneca (United Kingdom), Gilead Sciences, Inc. (United States), Sanofi (France), Merck & Co., Inc. (United States), Roche Holding AG (Switzerland), Pfizer, Inc. (United States), Novartis (Switzerland), Kulzer GmbH (Germany) and 3M (United States) are some of the key players profiled in the study. Dental Carpule Market Segmentation:
Scope | Sub-Segments |
---|
Distribution Channel | Online Channel,Offline Channel |
End-user | Hospitals,Dental Clinics,Home Care,Others |
Age Group | Children,Adults |
Material | Glass,Plastic,Metal |
On the basis of geography, the market of Dental Carpule has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Rising Number of Surgical Procedures across the Globe
Market Growth Drivers:
Increased Prevalence of Dental Disorders, Increase in Healthcare Expenditure, Technological Advancements in the field of Medical Science and Development of New Diagnostic Centre and Hospitals
Challenges:
Lack of Healthcare Professionals in Some Regions
Restraints:
Complexities Associated with Dental Procedures
Opportunities:
Robust Increase in Distribution Channels and Huge Investments and Franchising By Major Players
Key Target Audience
Dental Carpule Manufacturers, Research Professionals, Emerging Companies, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user
Market Leaders & Development Strategies
In December 2018, GlaxoSmithKline plc has reached agreement with Pfizer Inc to combine their consumer health businesses into a new world-leading Joint Venture. GSK will have a majority controlling equity interest of 68% and Pfizer will have an equity interest of 32% in the Joint Venture.